Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement

Factor-Xa inhibitors like edoxaban have been shown to have comparable or superior rates of stroke and systemic embolization prevention to warfarin while exhibiting lower clinically significant bleeding rates. The authors report a case of a man who presented with delayed, recurrent intracranial hemor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivakumar, Walavan, Garber, Sarah T., Schrock, Lauren E., House, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556834/
https://www.ncbi.nlm.nih.gov/pubmed/23365773
http://dx.doi.org/10.1155/2013/691840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556834/
https://www.ncbi.nlm.nih.gov/pubmed/23365773
http://dx.doi.org/10.1155/2013/691840

Ejemplares similares